24.11.2014 • News

BASF to Sell Omega-3 Production Plant to Marine Ingredients

BASF has agreed to sell its production facility for natural fish oils, medium-concentrated omega-3s, and customized bottled fish oil in Brattvåg, Norway, to Marine Ingredients for an undisclosed sum.

As part of the deal set to close in the first quarter of 2015. BASF's 47 employees at Brattvåg will transfer to Marine Ingredients.

With the acquisition, Marine Ingredients will gain control of omega-3 production, which the leading manufacturer of omega-3 softgel and liquid formulations sold in health food stores and directly to practitioners, said is central to its business.

BASF, also among the global market leaders in omega-3s, plans to focus its activity in future on the market segment for highly concentrated omega-3 fatty acids, following the acquisitions of Equateq (now BASF Pharma Callanish) in 2012 and Pronova Biopharma in 2013.

The German chemical giant said the highly concentrated omega-3 fatty acids for consumer health, clinical nutrition and pharmaceutical products are one of the key growth areas for its Nutrition & Health division.

 

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.